R-1,3-butanediol-based supplement
Term · Oncology and biomedicine · MLC-T-ONC-016333
A supplement composed of R-1,3-butanediol that may be used to increase the level of the ketone body beta-hydroxybutyrate (BHB), with potential protective and antineoplastic activities. Upon administration of R-1,3-butanediol-based supplement, R-1,3-butanediol is converted to BHB. BHB may activate the surface receptor hydroxycarboxylic acid receptor 2 (HCAR2) and induce the transcriptional regulator homeodomain-only protein (HOPX), thereby inhibiting cell proliferation in intestinal epithelial cells that express HCAR2 and HOPX.
| Identifier | MLC-T-ONC-016333 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | beta-hydroxybutyrate supplement; R-1,3-butanediol supplement |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016333",
"term": "R-1,3-butanediol-based supplement",
"field": "Oncology and biomedicine",
"definition": "A supplement composed of R-1,3-butanediol that may be used to increase the level of the ketone body beta-hydroxybutyrate (BHB), with potential protective and antineoplastic activities. Upon administration of R-1,3-butanediol-based supplement, R-1,3-butanediol is converted to BHB. BHB may activate the surface receptor hydroxycarboxylic acid receptor 2 (HCAR2) and induce the transcriptional regulator homeodomain-only protein (HOPX), thereby inhibiting cell proliferation in intestinal epithelial cells that express HCAR2 and HOPX.",
"synonyms": [
"beta-hydroxybutyrate supplement",
"R-1,3-butanediol supplement"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/r-13-butanediol-based-supplement/"
}
Record 13,955 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.